LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT

被引：0

作者：

De la Rubia Navarro, M. ^{[1
]}

Cortes, J. Ivorra ^{[1
]}

Garcia, E. Grau ^{[1
]}

Puig, L. Gonzalez ^{[1
]}

Albuixech, R. Negueroles ^{[1
]}

Cordellat, I. Martinez ^{[1
]}

Ortiz-Sanjuan, F. ^{[1
]}

Rodriguez, J. E. Oller ^{[1
]}

Rodriguez, S. Leal ^{[1
]}

Perales, C. Pavez ^{[1
]}

Gil, J. J. Fragio ^{[1
]}

Bernabeu, E. Vicens ^{[1
]}

Barcena, C. Riesco ^{[1
]}

Quispe, A. V. Huaylla ^{[1
]}

Sanchez, L. Mas ^{[1
]}

Munoz, P. ^{[1
]}

Herranz, C. Najera ^{[1
]}

Olmos, I. Canovas ^{[1
]}

Ivorra, J. A. Roman ^{[1
]}

机构：

[1] Hosp Univ La Fe, Reumatol, Valencia, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2944

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0435

引用

页码：1345 / 1346

页数：2

共 50 条

[21] The urine sediment and 24-hour proteinuria before and after the cyclophosphamide therapy cycle in patients with lupus nephritis - some of our experiences
Popadic, Peric A.
Raskovic, S.
Stefanovic, L.
Arandjelovic, S.
Bolpacic, J.
Djuric, V
Savic, N.
Spasic, S.
Plavsic, A.
Durutovic, D.
Delic, R.
Stosovic, R.
Bogic, M.
ALLERGY, 2010, 65 : 464 - 464
[22] Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
Bancha Satirapoj
Chagriya Kitiyakara
Asada Leelahavanichkul
Yingyos Avihingsanon
Ouppatham Supasyndh
BMC Nephrology, 18
[23] Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
Satirapoj, Bancha
Kitiyakara, Chagriya
Leelahavanichkul, Asada
Avihingsanon, Yingyos
Supasyndh, Ouppatham
BMC NEPHROLOGY, 2017, 18
[24] Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney function
Luo, Huiting
Zhou, Yangzhong
Chen, Gang
Ren, Qidong
Zhao, Jiuliang
Ye, Wenling
Qin, Yan
Li, Xuemei
LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
[25] Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
Andrese Aline Gasparin
Nicole Pamplona Bueno de Andrade
Vanessa Hax
Penélope Esther Palominos
Marina Siebert
Romulo Marx
Pedro Guilherme Schaefer
Francisco Veríssimo Veronese
Odirlei André Monticielo
BMC Rheumatology, 4
[26] Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
Gasparin, Andrese Aline
Bueno de Andrade, Nicole Pamplona
Hax, Vanessa
Palominos, Penelope Esther
Siebert, Marina
Marx, Romulo
Schaefer, Pedro Guilherme
Veronese, Francisco Verissimo
Monticielo, Odirlei Andre
BMC RHEUMATOLOGY, 2020, 4 (01)
[27] Urinary λ Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis
Hanaoka, Masanori
Gono, Takahisa
Kawaguchi, Yasushi
Kaneko, Hirotaka
Koseki, Yumi
Katsumata, Yasuhiro
Takagi, Kae
Ichida, Hisae
Baba, Sayumi
Okamoto, Yuko
Ota, Yuko
Kataoka, Sayuri
Yamanaka, Hisashi
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S238 - S238
[28] URINARY SOLUBLE VCAM-1 IS A USEFUL BIOMARKER OF DISEASE ACTIVITY AND TREATMENT RESPONSE IN LUPUS NEPHRITIS
Gasparin, A. A.
Pamplona Bueno de Andrade, N.
Hax, V.
Palominos, P.
Siebert, M.
Marx, R.
Shaefer, P.
Verissimo Veronese, F.
Monticielo, O.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1502 - 1503
[29] Urinary T Cells and Macrophages Strongly Reflect the Disease Activity, Kidney Function, and the Histopathologic Classification in Patients with Lupus Nephritis.
Wada, Yoko
Sakatsume, Minoru
Nakano, Masaaki
Narita, Ichiei
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S726 - S726
[30] SUCCESSFUL TREATMENT WITH BELIMUMAB AFTER INADEQUATE RESPONSE TO PREVIOUS THERAPEUTIC REGIMENS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. REAL LIFE EXPERIENCE
Athanassiou, P.
Tzanavari, A.
Katsavouni, C.
Banti, T.
Kostoglou-Athanassiou, I.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S82 - S82

← 1 2 3 4 5 →